177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Learn more about:
Related Clinical Trial
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Laser Tissue Welding – Distal Pancreatectomy Sealing Study
DOTATOC PET/CT for Imaging NET Patients
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery